The APS Report Weathers Its Critics

It comes as no great surprise that groups promoting the president’s Strategic Defense Initiative (SDI) have attempted to discredit the recently published American Physical Society study Science and Technology of Directed Energy Weapons (THE SCIENTIST, May 18, 1987, p. 11). The APS study, released on April 23, 1987, addressed the scientific feasibility of a ballistic missile defense utilizing high-intensity lasers and energetic particle beams as weapons. A panel of experts on directed en

Written byRobert Park
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

It comes as no great surprise that groups promoting the president’s Strategic Defense Initiative (SDI) have attempted to discredit the recently published American Physical Society study Science and Technology of Directed Energy Weapons (THE SCIENTIST, May 18, 1987, p. 11). The APS study, released on April 23, 1987, addressed the scientific feasibility of a ballistic missile defense utilizing high-intensity lasers and energetic particle beams as weapons. A panel of experts on directed energy technologies concluded, after a detailed 18-month study, that the required performance levels were far beyond the capabilities of existing technologies. They estimated that at least a decade of research would be required just to decide whether such weapons would ever be feasible.

The only technical challenge to the APS report came from two SDI scientists—Lowell Wood of Lawrence Livermore Laboratory and Gregory Canavan of Los Alamos National Laboratory, who had access to the report in the seven ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies